Follow-up to Nova: Inventory, Purchase Commitments, and Demand Quality
The main article already identified inventory and purchase commitments as Nova's new test. This follow-up isolates the core issue: not a liquidity squeeze, but a company using its balance sheet to underwrite demand that still sits partly on a non-firm backlog and a long sales cycle.
Where This Follow-up Starts
The main article already flagged inventory and purchase commitments as Nova's new test. The next step is to go one layer deeper, because this is not a simple excess-inventory story and it is not a liquidity-stress story either. It is a demand-quality question in an industry where the company itself says backlog is not a reliable indicator of actual sales and where the sales cycle for new customers, products, or applications may take longer than 12 months.
That is what makes the 2025 year-end numbers interesting. On one side, Nova finished the year with $1.646 billion of cash, deposits, and marketable securities, with working capital of $1.186 billion, and with $245 million of cash flow from operations. It also says explicitly that current cash reserves should be adequate to fund planned activities for at least the next twelve months. On the other side, inventory rose to $183.7 million, and the company disclosed about $153.0 million of non-cancelable purchase obligations for 2026 through 2028.
This is not a liquidity problem. It is a balance-sheet underwriting test. If order flow keeps converting as expected, this can look like smart preparation. If customer timing stretches, slips, or cools, inventory and commitments stay much more rigid than the softer language of backlog.
That chart matters because it points the reader to the right interpretation. Inventory and receivables did rise, but operating cash flow stayed positive and the balance-sheet buffer expanded sharply. So the risk is not that Nova has entered financial stress. The risk is subtler: Nova has chosen to absorb more of the friction between forecast demand and demand that actually turns into shipment, revenue, and cash.
Inventory Rose Mostly in the Preparation Layers
A superficial read says only that inventory increased by 17.3%. The better question is what kind of inventory increased. That breakdown matters because it shows the rise did not sit mainly in finished goods already built and waiting to ship. It sat mainly in earlier preparation layers.
| Inventory component | 2025 | 2024 | Change | What it implies |
|---|---|---|---|---|
| Raw materials | $58.4 million | $44.0 million | 32.7% | The sharpest increase came in the earliest layer, meaning preparation ahead of full production |
| Service inventory | $43.2 million | $36.2 million | 19.2% | Support for the growing installed base and service availability |
| Work in process | $41.6 million | $37.0 million | 12.3% | Another preparation layer spread across the production chain |
| Finished goods | $40.5 million | $39.4 million | 2.9% | Only a modest increase in the layer closest to shipment |
That is the key distinction. This is not mainly a picture of finished systems piling up in the warehouse. It is a picture of a company building availability across supply and service before all of the demand has fully converted into shipment. In demand-quality terms, that is less alarming than a blowout in finished goods, but it does not remove the issue. If customer forecasts slip, raw materials, work in process, and service inventory can still turn into excess that has to be carried or written down.
There is another nuance here. Nova is already recording a real income-statement cost for this choice. In 2025 it wrote down $8.56 million of inventory, compared with $7.82 million in 2024. That is not a collapse signal, especially against the revenue growth, but it does show that inventory carrying is not a theoretical discussion in this business. It already runs through earnings.
Purchase Commitments Turn Preparation into Obligation
The sharpest point actually sits in the commitments note. Nova says it is obligated under certain supplier agreements to purchase specified inventory items expected to be used during 2026 through 2028, and those non-cancelable purchase obligations stood at about $152.965 million at the end of 2025.
That number matters not just in absolute terms. It equals roughly 83% of year-end inventory. In other words, the preparation layer does not stop with what is already on the shelf or in production. It also has a meaningful contractual tail with suppliers.
Still, the interpretation should stay disciplined. These commitments are expected to be utilized over three years, not in one quarter. On top of that, the $1.646 billion liquidity cushion is about 10.8 times larger. Nova also says its principal liquidity needs are working capital, capital expenditures, additional acquisitions, and the new ERP, and it believes current reserves are sufficient for at least the next twelve months.
So the issue is not whether Nova can pay. It can. The issue is what exactly it is writing the check for: demand that is already close to revenue conversion, or a demand forecast that still has to pass through a long sales cycle, customer approvals, and possible delay.
Why Backlog Does Not Solve the Problem
This is where Nova's risk language is sharper than the usual equipment-company framing. The company says explicitly that backlog includes only those customer orders for which a delivery date has been specified. That sounds reassuring, but in the same breath it explains why backlog is still a limited forecasting tool: shipment dates may change, customers may cancel or delay with little or no penalty, and the ability to collect cancellation fees is not assured.
In other words, backlog is an operating tool, not insurance for working capital. That matters because in that same relationship Nova also says it schedules production based on order backlog and customer forecasts. So one part of the company is planning procurement and production around expected demand, while another part of the same filing reminds readers that this demand can move even after the preparation decision has already been made.
That risk becomes even more concrete in the sales-cycle disclosure. Nova says the sales cycle for new customers, products, or applications may take more than 12 months, and that during this period it may invest substantial funds and management effort without making any sale at all. It also says lengthy sales cycles expose the company to inventory obsolescence and volatile quarterly results. That matters because it ties marketing language, inventory, and accounting risk into one straight line.
This is also why demand quality matters more than demand quantity here. Aggregate demand may well still be strong, and the 31% revenue growth in 2025 supports that. But as long as part of that demand sits in long-cycle transactions, in customers that can defer decisions, and in a backlog that management itself refuses to present as a reliable indicator of actual sales, the rise in inventory and purchase commitments is not just a sign of confidence. It is also a sign that the balance sheet is absorbing part of the commercial risk.
Bottom Line
Nova does not look like a company that has lost control of inventory. There is also no evidence here that demand has broken. On the contrary, 2025 was a year of strong growth, positive cash generation, and exceptional liquidity. That is exactly why the conclusion needs to be stated carefully: liquidity answers the question of capacity, not the question of quality.
Inventory rose mainly in the early preparation layers, purchase commitments add a second layer of rigidity with suppliers, and the company itself warns that backlog is not firm enough to read near-term revenue quality straight out of it. So this is not a balance-sheet stress story. It is a story about a company choosing to buy itself availability and flexibility, at the price of carrying more demand risk on the balance sheet.
If demand keeps converting at the pace Nova is underwriting, that decision may look very smart in hindsight. If cycles lengthen, orders get delayed, or backlog converts into revenue more slowly than expected, that same strong balance sheet will look less like a comfortable cushion and more like the mechanism that absorbs the surprise before the income statement feels it. That is the real difference between strong growth and high-quality growth.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.